Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
567-05-013 ISMRM Abstract

A Comparative Study of Brain/Liver MR Image Quality between PETMR and standalone MR scanners in Clinical Practice

Primary: Contrast Mechanisms - Multi-Contrast
Secondary: Analysis Methods - Data Processing
567-05-013 · Novel Contrast Mechanisms I · Wednesday, 13 May, 4:00 PM–4:55 PM · Digital Posters Row H
Keywords: PET/MR 3.0T magnetic resonance imaging Correlation analysis Quantitative Analysis
Accepted
Dandan Hu 1, Jun Chen1,2, Pin Lv1, Hailong Zhang1, Jiaming Lu1, Bing Zhang1, Xin Zhang1, Ming Li1
1Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
2Radiology, Mayo Clinic, Rochester, United States of America
Presenting Author: Dandan Hu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Czernin J, Ta L, Herrmann K. Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients. J Nucl Med. 2014; 55(Supplement 2): 59S-62S.
2. Drzezga A, Barthel H, Minoshima S, Sabri O. Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases. J Nucl Med. 2014;55(Supplement 2):47S-55S.
3. Shen CP, Vanichsarn CT, Pandey AC, et al. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?. Int J Cardiovasc Imaging. 2023;39(1):201-208.
4. Catalano OA, Lee SI, Parente C, et al. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. Eur J Nucl Med Mol Imaging. 2021;48(4):1235-1245.
5. Li X, Zhang Y, Wu J, et al. Multimodal metabolic and functional network signatures for diagnosis of parkinson's disease: a PET/MR study. Sci Rep. 2025;15(1):35685
6. Liu Y, Xiao L, Lyu M, Zhu R. Eliminating electromagnetic interference for RF shielding-free MRI via k-space convolution: Insights from MR parallel imaging advances. J Magn Reson. 2024;369:107808.
7. M S H, Joseph P, George S. Electromagnetic interference shielding: a comprehensive review of materials, mechanisms, and applications. Nanoscale Adv. 2025;7(15):4510-4534.
8. Huang W, Liu X, Wang Y, et al. Ultra‑Broadband and Ultra-High Electromagnetic Interference Shielding Performance of Aligned and Compact MXene Films. Nanomicro Lett. 2025;17(1):234.
9. Quick HH. Integrated PET/MR. J Magn Reson Imaging. 2014;39(2):243-258.
10. Sotoudeh H, Sharma A, Fowler KJ, McConathy J, Dehdashti F. Clinical application of PET/MRI in oncology. J Magn Reson Imaging. 2016;44(2):265-276.
11. Drzezga A, Barthel H, Minoshima S, Sabri O. Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases. J Nucl Med. 2014;55(Supplement 2):47S-55S.
12. Qiao Y, Xing F, Liu Y, Liang T. Precise Non-invasive Liver Cirrhosis Quantification via Multimodal Stiffness-Structural Fusion Imaging. J Vis Exp. 2025;(221):10.3791/68666.
13. Garsa A, Buckey CR, Davis BJ, et al. ACR-ARS Practice Parameter for Image-Guided Radiation Therapy (IGRT). Am J Clin Oncol. 2025;48(11):529-539.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/567-05-013